He & She MD Review: Following the Care Path From Intake to Pharmacy and Follow-Up

A medication arriving at your door is only one part of an online weight-management service. The more consequential questions are who reviews your history, who writes the prescription, which pharmacy fills it and who responds when something needs attention. He & She MD advertises all of those stages, including a short online assessment, clinician review, pharmacy delivery and ongoing messaging. Its documentation also contains conflicting clinical-entity descriptions, inconsistent prices and older membership terms that do not map neatly onto today’s advertised plans.

This review follows that care pathway rather than treating the lowest advertised monthly figure as the whole service. Public pages consulted October 19, 2026 describe compounded semaglutide and tirzepatide, injectable and oral options, and access to certain brand medications when appropriate and available. Those are provider statements, not independently verified credentials or outcomes. The practical task before enrolling is to obtain one coherent explanation of the selected product, responsible clinician, dispensing pharmacy, payment schedule and follow-up arrangements.

At a glance

Clinical responsibility needs clarification: The FAQ identifies Wasef Health, PC, while the terms describe a technology platform connecting patients with Beluga Health or similar professional entities.
Sources: [8] [7]
Intake is not delivery: The plans page advertises an approximately five-minute assessment, roughly 24-hour provider review and a separate two-to-three-day medication-delivery stage.
Sources: [5]
Annual-price condition: Injectable semaglutide starts at $99 per month only with purchase of 12 months’ supply; the plans page lists $1,188 paid annually.
Sources: [12] [5]
Shipping geography: The provider advertises GLP-1 shipping to every U.S. state except Louisiana, with no delivery to PO boxes; that does not independently confirm clinical availability.
Sources: [5]
Included support has limits: Plans advertise ongoing provider support and unlimited messaging, but the telemedicine consent says asynchronous services are not emergency services and patient data are not monitored 24/7.
Sources: [5] [7]

Establish who is responsible before starting

He & She MD presents itself as a telehealth clinic covering weight loss, longevity, hormone therapy and performance health. Its plans page names Ozita Cooper, MD, as chief medical officer and describes her as dual board-certified in obesity and emergency medicine. These are the site’s representations; the consulted documentation does not independently verify credentials. A leadership biography also does not identify the individual who will review a particular patient’s questionnaire or manage subsequent concerns.

The clinical-entity descriptions are harder to reconcile. The FAQ names Wasef Health, PC, care of Michael Wasef, MD, and provides contact@wasef-health.com and an office address at 5260 78th Ave N, PO Box 1697, Pinellas Park, Florida. The terms, carrying a November 1, 2022 revision date, instead say He and She MD does not provide medical services and connects users with professionals employed or contracted by Beluga Health, P.A., or similar entities.

Those descriptions may reflect different arrangements or different periods, but the pages do not resolve that question. Before submitting sensitive information, ask which professional entity will provide your care, where its consent and privacy documents appear, and how to contact it independently of customer support. Our explanation of clinician and platform responsibilities provides a useful framework for separating a storefront, a medical practice and a dispensing pharmacy.

Sources: [8] [7] [5]

What the intake and review actually promise

The advertised first step is a free online assessment taking about five minutes. It asks about goals and medical history, after which the site says a licensed, board-certified U.S. physician—an MD or DO—reviews the questionnaire. Another process graphic describes provider review in approximately 24 hours. Neither statement makes five minutes the length of a medical consultation, and the review estimate should not be read as a promise that medicine will arrive the next day.

The terms require users to be at least 18, located in a state where the relevant service operates and willing to accept the terms. He & She MD also says patients are charged only if medication is prescribed; someone who is not a candidate pays nothing. That is a useful distinction from paying simply to complete an assessment, but it does not guarantee a prescription or establish that every advertised product is available in every otherwise covered state.

The consulted documentation does not settle whether these plans require initial or periodic laboratory testing, whether testing would cost extra, or when a live conversation becomes necessary. Prepare a medication and supplement list, relevant health history and questions about pregnancy plans for the clinician, consistent with NIDDK guidance. The first-consultation preparation guide can help organize that discussion without assuming that an online questionnaire alone resolves every clinical issue.

Sources: [7] [5] [2]

Identify the product, not just the ingredient

He & She MD advertises compounded semaglutide and tirzepatide, alongside Wegovy, Ozempic, Zepbound and Mounjaro when clinically appropriate and available. Separate injectable listings describe subcutaneous administration; separate oral listings market tablets as non-injectable options. These are materially different presentations. A reference to semaglutide or tirzepatide alone does not tell a prospective patient which formulation, route or branded product a clinician might prescribe, or whether its price matches the highlighted plan.

The provider’s compounded-medication article acknowledges that compounded preparations are not FDA approved and have not undergone FDA review for safety, effectiveness or quality. FDA approval belongs to a specific product, not to a clinic, pharmacy or every formulation containing an ingredient. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Nonapproval alone does not establish clinical inequivalence.

The oral pages leave important identification questions unanswered: the consulted documentation does not establish their specific formulations, added ingredients, manufacturer or product-specific regulatory status. Their pricing tables also carry inconsistent labels, discussed below. Before payment, request the exact product description and pharmacy label information. Published trials should not be treated as measured results for this provider, its compounded preparations or different routes; the site’s menu is not itself evidence that those offerings produce equivalent outcomes.

Sources: [5] [12] [10] [6] [11] [9] [1] [3] [4]

Reconcile the bill before authorizing the prescription

The plans page offers monthly, three-month, six-month and annual choices for compounded semaglutide and tirzepatide, shown below. Longer-period options specify collection amounts; they are alternatives to monthly billing, not mandatory prepayment for everyone. The injectable semaglutide listing conditions its starting $99 monthly figure on purchasing 12 months’ supply, advertises the same price at every dose and accepts HSA/FSA payments. Purchase duration does not establish shipment cadence or mean all medicine arrives together.

Material discrepancies remain. Injectable semaglutide’s product page lists $99/month for 12 months, $199 for six, $219 for three and $249 for one. Injectable tirzepatide lists $159, $289, $309 and $339/month for those respective durations. The oral semaglutide page lists $209, $239, $259 and $279/month, but labels its table injectable semaglutide. Oral tirzepatide lists $269, $289, $309 and $339/month under an incongruous injectable-sermorelin heading. These are advertised figures requiring reconciliation, not interchangeable checkout quotes.

The homepage adds renewal qualifications: a $139/month introductory six-month offer renews at $1,194 per six months, equivalent to $199/month; a $199/month introductory six-month offer renews at $1,734, equivalent to $289/month. It attributes savings of $360 and $540 respectively. Its annual $99 promotion also appears beside “This offer has ended.” Separately, a $25 first-prescribed-treatment discount requires consultation and eligibility. Confirm the applicable offer, first collection and subsequent charge in writing rather than assuming the lowest figure persists.

Advertised compounded-medication options on the plans page; product-page prices differ
Billing option	Compounded semaglutide	Compounded tirzepatide
Monthly	$199/month, billed monthly	$299/month, billed monthly
Three months	$149/month; pay $447 every three months; advertised savings $270	$209/month; pay $627 every three months; advertised savings $270
Six months	$139/month; pay $834 every six months; advertised savings $360	$199/month; pay $1,194 every six months; advertised savings $540
Annual	$99/month; pay $1,188 annually	$159/month; pay $1,908 annually

Sources: [5] [12] [10] [6] [11] [8]

The pharmacy handoff has unresolved boundaries

The plans page identifies Specialty Medical Drugstore LLC, doing business as GoGoMeds, and F&F Pharmacies Inc, doing business as Jungle Jim’s Pharmacy, as prescription-fulfillment partners. Naming partners is useful, but fulfillment does not necessarily mean either partner prepares every compounded formulation. The consulted pages do not identify which pharmacy compounds each product or explain how the selected prescription is routed between partners. Ask for the dispensing pharmacy’s name and contact information before shipment.

The description of Jungle Jim’s creates a specific operational question. He & She MD says it holds licenses in 44 states, yet lists ten states where it lacks a license: California, Nevada, New Jersey, North Carolina, Texas, Massachusetts, Mississippi, New Hampshire, West Virginia and Delaware. The same passage says it cannot dispense sterile compounds. That count and those restrictions do not reconcile neatly with the broader GLP-1 shipping claim.

This does not establish that patients in those states cannot receive any service. It means the public documentation does not show which pharmacy covers the gap or handles a particular sterile injectable. Pharmacy-channel restrictions matter even when the platform advertises broad geographic reach. Use the questions in our pharmacy-handoff guide to establish who fills the prescription, who explains the label and whom to contact about a preparation or shipment problem.

Sources: [5]

Delivery estimates need a starting point

He & She MD says GLP-1 orders ship to all U.S. states except Louisiana; its separate longevity and hormone-therapy offerings advertise nationwide shipping. It does not ship to PO boxes and describes packages as discreet. These shipping statements should not be expanded into confirmed prescribing availability for every product and state. The provider also advertises free expedited delivery on every order, which removes an advertised shipping charge but does not make treatment free.

The process graphic places “2–3 DAYS” over its medication-delivered stage and says prescriptions ship directly from a U.S.-licensed pharmacy, with tracking emailed to the patient. It does not clearly define when that clock starts. Clinician review, pharmacy processing, dispatch and arrival are separate events. An estimate attached to delivery should not be converted into a guaranteed interval from questionnaire submission, particularly when the review itself is advertised as approximately 24 hours.

A compounded-semaglutide article says medicine, syringes and instructions usually ship cold-packed. “Usually” is not an individual shipping guarantee, and the pages do not document the full temperature-control process. FDA explicitly advises not using an injectable GLP-1 drug that arrives warm or inadequately refrigerated and contacting the provider or dispensing pharmacy. Our guide to warm injectable deliveries and FDA advice explains that boundary without asking readers to judge product usability from appearance alone.

Sources: [5] [8] [9] [1]

Separate continuing care from customer availability

The plans page says every plan includes medication if prescribed, injection supplies, free shipping, ongoing provider support and unlimited messaging, without membership fees. The homepage also promotes an app for tracking progress and adjusting the plan. Those features describe more than a one-time prescription sale, but they do not establish the frequency of clinical follow-up, which professional reviews progress or how quickly a medical message receives a response.

The injectable semaglutide page advertises 24/7 support. The telemedicine consent supplies an important limit: asynchronous services are not emergency services, and personal data are not monitored around the clock. Unlimited messaging therefore should not be interpreted as continuous clinician observation. Ask whether support means administrative assistance, clinical review or both, and how an unresolved medication concern is escalated. The consulted pages do not provide guaranteed medical-message response times or clinician schedules.

Privacy also depends on the channel used. The terms warn that ordinary text messages and emails are not encrypted and could be intercepted. A general security assurance should not erase that exception or be extended automatically to every communication method. For continuing care, establish where to send medical details, who reads them and which contact path is appropriate for billing versus clinical questions. NIDDK describes meaningful follow-up as attention to tolerance and response, not simply another payment.

Sources: [12] [5] [8] [7] [2]

Clarify how payments and care can end

He & She MD does not accept insurance. It also says it does not provide superbills or communicate with insurers; patients may submit receipts themselves, but reimbursement is not guaranteed. HSA/FSA acceptance is a separate advertised payment feature, not confirmation that a particular account will reimburse every charge. This self-pay structure makes the exact billing interval especially important because the plans page offers both monthly billing and larger periodic collections.

The older terms describe pausing a membership by turning off automatic payments through a secure account or emailing support@heandshemd.com. They also say that remaining on-demand for eight consecutive weeks or more without scheduling a Continuation Visit may lead to membership cancellation without notice. Current GLP-1 plans, however, advertise no membership fees. The documentation does not establish that these older membership provisions govern those plans, so they should not be treated as a complete current cancellation policy.

The consulted terms excerpts do not establish the full cancellation, return or refund rules for current GLP-1 purchases. Before authorizing payment, request the applicable renewal notice deadline, cancellation method, refund boundaries and treatment of payments already collected. Ask separately what happens to clinical messaging, unfilled prescriptions and scheduled shipments after cancellation. Stopping a subscription is not automatically a refund, and a longer advertised package does not by itself establish a minimum commitment or dispensing quantity.

Sources: [5] [7]

Questions & answers

Who would actually provide my medical care?

The public documentation does not give one reconciled answer. The FAQ identifies Wasef Health, PC, care of Michael Wasef, MD, while the older terms describe access to Beluga Health or similar professional entities through a technology platform. Ask for the entity and clinician assigned to your specific service, along with their contact details and applicable consent documents.

Sources: [8] [7]

Can I buy injectable semaglutide for $99 one month at a time?

That is not what the advertised starting price says. The injectable listing ties $99 per month to purchasing 12 months’ supply, and the plans page lists $1,188 paid annually. Its monthly plan is $199, while the injectable product page lists $249 for one month. The discrepancy and the homepage’s expired-offer notice make confirmation essential before payment.

Sources: [12] [5] [8]

Will an annual purchase arrive in one shipment?

The consulted pages do not establish that. An annual collection amount and a reference to purchasing 12 months’ supply do not explain dispensing frequency, quantities per shipment or refill checks. Ask how many shipments are planned, when the pharmacy releases them and whether later shipments depend on clinical follow-up. Do not interpret the package duration as a delivery schedule.

Sources: [5] [12]

Does the oral option have a clearly documented price and formulation?

The oral pages publish prices, but their table labels are inconsistent: oral semaglutide uses an injectable-semaglutide heading, and oral tirzepatide uses an injectable-sermorelin heading. The consulted documentation also leaves formulation, added ingredients and manufacturer unresolved. Request an exact product description and written quote rather than assuming a tablet is the same product or service as an injectable option.

Sources: [6] [11]

Does 24/7 support mean a clinician monitors my messages continuously?

No continuous clinical monitoring is established. A product page advertises 24/7 support, but the telemedicine consent explicitly says asynchronous services are not emergency services and data are not monitored 24/7. Plans include unlimited messaging, yet the pages do not guarantee clinical response times. Ask which channel reaches a clinician and what the service’s escalation process is.

Sources: [12] [5] [7]

Can I use insurance or cancel through the older membership-pause process?

He & She MD says it does not accept insurance, provide superbills or handle insurer communications. Patients may submit receipts without guaranteed reimbursement. The older terms allow membership pauses through an account or support email, but their application to current no-membership-fee GLP-1 plans is unresolved. Obtain the current cancellation and refund policy for the actual plan before relying on that process.

Sources: [5] [7]

Our assessment

He & She MD documents a recognizable telehealth pathway: online intake, clinician review, prescription fulfillment, delivery and ongoing messaging, with useful disclosures about included services and self-pay billing. Its documentation is less dependable at the handoffs. Clinical-entity descriptions differ, pharmacy coverage has unresolved restrictions, prices conflict across pages and older membership terms do not clearly explain current GLP-1 cancellation rights. These gaps do not prove that care is unavailable or inadequate. They do mean the advertised pathway needs a patient-specific written explanation before purchase. The most useful next step is to request one consolidated confirmation covering the exact product, clinician, pharmacy, first and renewal charges, shipment cadence, response expectations and cancellation terms.

Visit He & She MD’s official site ↗

This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.

FOLLOW THE EVIDENCE

Research behind treatment claims

Use these studies to assess the type of outcome a treatment claim describes. They did not test this provider or establish results for its products.

SURMOUNT-5: What a Direct Weight-Loss Comparison Can—and Cannot—Tell You About Ongoing Care
Tirzepatide produced greater average weight and waist reductions than semaglutide over 72 weeks. Understanding the trial’s design matters just as much as understanding the difference.
After the Weight Loss: What SURMOUNT-4 Means for Continuity of Care
Randomized tirzepatide withdrawal separates maintaining a treatment effect from finishing a course. Reading its two baselines—and newer maintenance-dose research—shows what the evidence can and cannot tell patients changing care.

Explore the science library →

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

He & She MD Review: Following the Care Path From Intake to Pharmacy and Follow-Up

At a glance

01Establish who is responsible before starting

02What the intake and review actually promise

03Identify the product, not just the ingredient

04Reconcile the bill before authorizing the prescription

05The pharmacy handoff has unresolved boundaries

06Delivery estimates need a starting point

07Separate continuing care from customer availability

08Clarify how payments and care can end